Image Trademark with Serial Number 88056022
Status: 700 - Registered
Serial Number
88056022
Registration Number
5789590
Status
700 - Registered
Status Date
2019-06-25
Filing Date
2018-07-27
Registration Number
5789590
Registration Date
2019-06-25
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
260502, 261313, 261316, 261321 - Plain single line triangles. Two quadrilaterals. Quadrilaterals touching or intersecting. Quadrilaterals that are completely or partially shaded.
Published for Opposition Date
2019-01-15
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
RICHARDS, LESLIE L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a large equilateral triangle with one side of the triangle running horizontally, with a smaller equilateral triangle near the point of the triangle and a band running from the bottom side to the top side of the triangle parallel to the right side of the triangle. A second bar lies to the right of the triangle as a shadow of the large triangle.
Goods and Services
Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for chelation treatments; Medicinal preparations for promoting men's health, namely, treating erectile dysfunction, andropause, and male fertility, and performing testosterone replacement therapies; Medicinal preparations for promoting women's health, namely, treating menopause and female fertility; Medicinal preparations for hormone replacement therapy; Medicinal preparations for weight management; Medicinal preparations for prolotherapy treatments to treat inflammation, localized pain, generalized pain, and ligament laxity; Medicinal preparations for promoting animal health in the nature of infections, pain, inflammation, cancer, autoimmune disease, and ocular disease; Medicinal preparations for oncology treatments; Medicinal preparations for pain management; Prescription medicines, namely, intravenous pharmaceutical preparations for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, topical medications for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Prescription medicines, namely, custom compounded medications for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, custom compounded medications for intravenous administration for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Prescription medicines, namely, custom compounded medications for topical administration for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Prescription medicines, namely, custom compounded medications for nasal administration for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies; Medicinal preparations for the body to be applied in the form of intravenous fluids for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Medicinal preparations for the body to be applied in the form of topical ointments for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Medicinal preparations for the body to be applied in the form of nasal sprays for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies; Custom compounded medicinal preparations for the body to be applied in the form of intravenous fluids for the treatment of cancer, cardiovascular disease, weight loss, diabetes, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Custom compounded medicinal preparations for the body to be applied in the form of topical ointments for the treatment of cancer, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain; Custom compounded medicinal preparations for the body to be applied in the form of nasal sprays for weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, allergies, and neurotransmitter deficiencies
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-08-03
Primary Code
005
First Use Anywhere Date
2018-11-26
First Use In Commerce Date
2018-11-26
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Scott F. Gibson
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-07-31 | NEW APPLICATION ENTERED IN TRAM |
2018-08-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-08-04 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2018-11-14 | ASSIGNED TO EXAMINER |
2018-11-16 | EXAMINERS AMENDMENT -WRITTEN |
2018-11-16 | EXAMINERS AMENDMENT E-MAILED |
2018-11-16 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2018-11-16 | EXAMINER'S AMENDMENT ENTERED |
2018-11-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-12-06 | ASSIGNED TO LIE |
2018-12-26 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-01-15 | PUBLISHED FOR OPPOSITION |
2019-01-15 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-03-12 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-05-07 | TEAS STATEMENT OF USE RECEIVED |
2019-05-21 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2019-05-07 | USE AMENDMENT FILED |
2019-05-22 | STATEMENT OF USE PROCESSING COMPLETE |
2019-05-23 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2019-05-24 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2019-06-25 | REGISTERED-PRINCIPAL REGISTER |
2019-09-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-09-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-08-12 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-08-12 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-08-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |